Paterson's Research Note re Infusions (combining comments from pages 1 and 2),
"While we have not assumed it in our DCF (discounted cash flow) model, we also think there is a reasonably high probability that AHZ will win another large hospital contract in 2017/ 2018. Our cautious optimism regarding new contract wins is due to the fact that many competing infusion pumps have recently been subject to safety recalls."
3D (and TAVR) Page 3
"AHZ intends to bring to market a curved patch and a TAVR valve...in our view they are likely to make material contributions to the bottom line within the first full year of their launch...however due to analyst conservatism (basically because they haven't been launched) we do not ascribe any value on these two products in this note"
Paterson's Research Note re Infusions (combining comments from...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |